BANK VONTOBEL/CALL/CVS HEALTH/62/0.1/20.09.24 Stock

Warrant

DE000VD5J4C8

Market Closed - Boerse Frankfurt Warrants 13:56:39 2024-06-26 EDT
0.26 EUR 0.00% Intraday chart for BANK VONTOBEL/CALL/CVS HEALTH/62/0.1/20.09.24
Current month+17.65%
1 month+91.18%
Date Price Change
24-06-26 0.26 0.00%
24-06-25 0.26 -16.13%
24-06-24 0.31 +6.90%
24-06-21 0.29 -3.33%
24-06-20 0.3 0.00%

Real-time Boerse Frankfurt Warrants

Last update June 26, 2024 at 01:56 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD5J4C
ISINDE000VD5J4C8
Date issued 2024-05-03
Strike 62 $
Maturity 2024-09-20 (86 Days)
Parity 10 : 1
Emission price 0.15
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.35
Lowest since issue 0.082
Spread 0.01
Spread %3.70%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
60.63 USD
Average target price
69.1 USD
Spread / Average Target
+13.96%
Consensus